148
Views
7
CrossRef citations to date
0
Altmetric
Articles

Comparison of efficacy of nanoparticles synthesized from leaves and flowers of Russelia equisitiformis

, &
Pages 75-81 | Received 24 Jul 2020, Accepted 18 Oct 2020, Published online: 22 Dec 2020
 

Abstract

The present study was focused on synthesis of silver nanoparticles using Russelia equisitiformis plant (RelAgNps) and flower extracts (RefAgNps). Thus, the nanoparticles synthesis was confirmed using UV spectrometry and the FT-IR results showed the presence of similar compounds in the plant extract and FESEM-EDAX reveals the size, shape, and elemental composition of synthesized nanoparticles. The antioxidant activity of the RefAgNps from flower extract and RelAgNps from leaf extract was observed at the concentration of 25 μg/mL but the percentage of antioxidant activity of flower extract was comparatively higher than the leaf extract. This plant is also known to have antidiabetic activity and thus leaf extract and flower extract mediated nanoparticles is also known to have alpha amylase inhibition activity at the concentration of 12.5 and 100 μg/mL, respectively. Molecular docking of the plant compounds10-O-cinnamoyl sinuatol and rehmaglutin B were docked with alpha amylase enzyme proves the same with the binding energy of −9.1 kcal/mol. Thus, to the best of our knowledge this is the first-time nanoparticles have been synthesized using R. equisitiformis flower and leaf extract and observed to have potent antioxidant and antidiabetic activity.

Acknowledgements

The authors are thankful to B.S. Abdur Rahman Institute of Science & Technology, Chennai for providing research facilities in School of Life sciences. Also, they acknowledge the Ministry of Science and Technology, Department of Science and Technology (KIRAN Division) (GoI), New Delhi (Ref No. DST/WOS-B/2018/1583-HFN (G)).

Conflict of interest

The authors have no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.